Pharmaids Pharmaceuticals quarterly results and financials

Pharmaids Pharmaceuticals (BSE 524572)₹30.00+5.01%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Pharmaids Pharmaceuticals reported sales of ₹4.11 Cr, down 38.2% from Jun 2025, and net profit of ₹1.87 Cr. For the year to Mar 2026, sales were ₹27.84 Cr and net profit −₹11.56 Cr.

Sales (Jun 2026): ₹4.11 Cr
Net profit (Jun 2026): ₹1.87 Cr
Sales (FY Mar 2026): ₹27.84 Cr
Net profit (FY Mar 2026): −₹11.56 Cr
EPS (Jun 2026): ₹0.64
Borrowings (Mar 2026): ₹23.37 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Pharmaids Pharmaceuticals quarterly results

₹ crore unless stated; each column is a quarter.

Pharmaids Pharmaceuticals Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	0.01	5.80	4.72	5.23	4.70	4.76	6.65	8.59	5.42	7.17	4.11
Expenses	1.03	2.46	11.42	8.16	7.68	7.62	8.69	12.07	13.98	7.97	7.54	4.89
Operating Profit	−1.01	−2.42	−5.57	−3.40	−2.40	−2.88	−3.89	−5.36	−5.31	−2.50	−0.33	−0.74
OPM %	—	−12,150.0%	−96.0%	−72.1%	−46.0%	−61.4%	−81.8%	−80.6%	−61.8%	−46.2%	−4.7%	−18.2%
Other Income	−0.27	0.77	0.13	−0.08	0.09	0.00	0.14	0.05	3.04	−0.33	0.02	4.26
Interest	0.00	0.03	0.76	0.25	0.34	0.49	1.00	1.19	0.92	0.73	0.64	0.61
Depreciation	0.00	0.03	0.62	0.56	0.60	0.63	0.61	0.60	0.46	0.47	0.47	0.48
Profit before tax	−1.30	−1.74	−6.85	−4.32	−3.28	−4.02	−5.41	−7.15	−3.70	−4.04	−1.47	2.42
Tax %	−60.4%	−33.5%	−7.7%	−27.3%	−30.5%	−24.9%	−11.0%	−26.0%	−30.6%	−34.2%	−25.3%	22.5%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.99	0.00	0.00	3.99
Net Profit	−0.51	−1.14	−6.32	−3.11	−2.26	−3.02	−4.79	−5.28	−2.58	−2.64	−1.08	1.87
EPS (Rs)	−0.24	−0.55	−1.58	−0.77	−0.56	−0.56	−1.13	−1.40	−0.72	−0.71	−0.52	0.64

Pharmaids Pharmaceuticals profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Pharmaids Pharmaceuticals Profit and loss
	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	3.93	0.00	15.09	19.40	27.84	25.29
Expenses	3.82	9.92	27.54	32.28	41.48	34.38
Operating Profit	0.12	−9.88	−12.33	−12.74	−13.50	−8.88
OPM %	3.3%	—	−81.7%	−65.6%	−48.5%	−35.1%
Other Income	0.03	0.00	0.04	0.02	2.76	6.99
Interest	0.00	0.00	1.57	2.09	3.51	2.90
Depreciation	0.00	0.01	1.71	2.43	2.02	1.88
Profit before tax	0.15	−9.92	−15.61	−17.29	−16.32	−6.79
Tax %	0.0%	−23.7%	−24.2%	−21.8%	−28.9%	—
Exceptional items	0.00	0.00	−0.84	−0.09	2.45	6.98
Net Profit	0.14	−7.55	−11.84	−13.50	−11.56	−4.43
EPS (Rs)	0.16	−3.53	−2.27	−3.07	−3.33	−1.31
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	—

Pharmaids Pharmaceuticals balance sheet

₹ crore, at each year end.

Pharmaids Pharmaceuticals Balance sheet
	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.30	21.49	35.24	35.26	35.31
Reserves	−1.60	1.03	36.85	24.11	12.42
Borrowings	0.00	0.00	8.51	38.92	23.37
Other Liabilities	2.45	2.14	10.81	21.65	16.30
Total Liabilities	11.15	24.66	91.41	120	87.40
Fixed Assets	0.02	0.12	63.40	76.60	53.96
CWIP	0.46	2.01	7.03	4.54	6.12
Investments	0.00	3.30	0.00	0.00	0.00
Other Assets	10.67	19.23	20.98	38.80	27.32
Inventories	0.88	0.00	3.58	12.15	0.40
Trade receivables	1.33	1.40	2.69	3.12	3.44
Cash & equivalents	0.42	12.77	4.82	0.83	0.14
Total Assets	11.15	24.66	91.41	120	87.40

Pharmaids Pharmaceuticals cash flow

₹ crore, for each year.

Pharmaids Pharmaceuticals Cash flow
	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−0.27	−4.03	−10.63	−15.12	−4.07
Cash from investing activity	0.46	−4.92	−74.74	−12.17	23.25
Cash from financing activity	0.00	21.24	77.43	23.28	−19.91
Net cash flow	0.22	12.39	−7.98	−4.00	−0.70
Capex	0.00	1.66	22.87	12.46	4.46
Free cash flow	−0.25	−5.68	−33.31	−27.35	11.04
CFO / OP %	−199.9%	41.1%	86.1%	118.0%	30.0%

Pharmaids Pharmaceuticals ratios

Working-capital days and returns, by year.

Pharmaids Pharmaceuticals Ratios
	Mar 2022	Mar 2024	Mar 2025	Mar 2026
Debtor days	124	65	59	45
Inventory days	91	112	347	9
Days payable	236	159	464	59
Cash conversion cycle	−22	16	−60	−7
Working capital days	−17	−68	−159	−171
ROCE %	—	−25.9%	−17.4%	−18.4%

Pharmaids Pharmaceuticals: frequently asked questions

What are the latest quarterly results of Pharmaids Pharmaceuticals?

For the Jun 2026 quarter, Pharmaids Pharmaceuticals reported sales of ₹4.11 Cr, down 38.2% year on year and net profit of ₹1.87 Cr. The operating margin was −18.2%.

What is the annual revenue of Pharmaids Pharmaceuticals?

Pharmaids Pharmaceuticals' sales for the year to Mar 2026 were ₹27.84 Cr; over the last twelve months they were ₹25.29 Cr.

What is the net profit of Pharmaids Pharmaceuticals?

Net profit for the year to Mar 2026 was −₹11.56 Cr, and −₹4.43 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.31.

How much debt does Pharmaids Pharmaceuticals have?

Pharmaids Pharmaceuticals reported borrowings of ₹23.37 Cr at Mar 2026, against cash and equivalents of ₹0.14 Cr.

What is the free cash flow of Pharmaids Pharmaceuticals?

Cash from operations was −₹4.07 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹11.04 Cr.

Loading…